Previous close | 56.87 |
Open | 56.10 |
Bid | 58.01 x 1000 |
Ask | 58.56 x 1400 |
Day's range | 54.87 - 58.56 |
52-week range | 46.93 - 93.80 |
Volume | |
Avg. volume | 224,880 |
Market cap | 1.415B |
Beta (5Y monthly) | 1.08 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
SANTA BARBARA, Calif., May 09, 2022--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its financial results for the first quarter ended March 31, 2022.
SANTA BARBARA, Calif., April 28, 2022--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended March 31, 2022 after the market closes on Monday, May 9, 2022, and will host a conference call at 4:30 pm ET that day to discuss those results.
SANTA BARBARA, Calif., April 26, 2022--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that it has entered into a $225 million term loan financing facility with funds managed by Oaktree Capital Management, L.P. ("Oaktree").